|
Jul 30
|
Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 29
|
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 25
|
REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
|
|
Jul 23
|
Harmony Biosciences Advances Pipeline While Navigating Analyst Caution
|
|
Jul 22
|
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025
|
|
Jul 17
|
Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again
|
|
Jul 15
|
3 Reasons Growth Investors Will Love Harmony Biosciences (HRMY)
|
|
Jul 15
|
HRMY vs. ILMN: Which Stock Should Value Investors Buy Now?
|
|
Jul 15
|
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?
|
|
Jul 15
|
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
|
|
Jul 14
|
Mizuho Reaffirms “Outperform” on Harmony Biosciences (HRMY) for BP1.15205 Data
|
|
Jul 10
|
Harmony Biosciences Preclinical Data for Narcolepsy Drug BP1.15205 Shows Promise
|
|
Jul 10
|
H.C. Wainwright Remains Bullish on Harmony Biosciences Holdings (HRMY)
|
|
Jun 24
|
Needham Reiterates a Buy Rating on Harmony Biosciences (HRMY)
|
|
Feb 24
|
Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now?
|
|
Feb 24
|
Harmony Biosciences (HRMY) Upgraded to Strong Buy: Here's Why
|
|
Feb 24
|
5 High Earnings Yield Value Stocks to Buy Amid Market Volatility
|
|
Feb 19
|
Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug
|
|
Feb 19
|
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
|
|
Feb 19
|
Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia
|